人类绒毛膜促性腺激素分泌(HCG) 市场：依产品类型、治疗应用、通路和地区划分。

预计到 2026 年，人类绒毛膜促性腺激素分泌(HCG) 市值将达到 29.6 亿美元，到 2033 年将达到 31.2 亿美元。预计从 2026 年到 2033 年，其复合年增长率将达到 3.68%。

人类绒毛膜促性腺激素分泌(HCG) 是一种受精卵着床后由胎盘分泌的荷尔蒙。这种激素支持卵子的正常发育，并促进卵巢排卵。 HCG 主要用于治疗不孕症女性，以诱导排卵。在男性中，它主要用于提高精子数量，也可用于治疗因脑下垂体疾病或其他原因导致睪丸未自然下降至阴囊的年轻男性。 HCG 通常透过皮下或肌肉注射给药。在妇产科医师或药师的指导下，HCG 也可在家中自行注射。 HCG 水平可透过尿液检查或血液检测进行测量。某些检测方法可以精确测量其浓度。这些检测主要用于筛检，以识别或确认妊娠，或检测先天性异常。这种荷尔蒙刺激黄体，黄体产生孕酮以维持怀孕。

市场动态

预计市场主要企业越来越多地采用非内生性成长策略，例如合作和收购，将推动预测期内的市场成长。例如，2021年1月，科技公司默克公司宣布与医疗科技公司皇家飞利浦建立多年合作关係，共同开发用于高度个人化生育治疗的临床级数位化解决方案。

本报告的主要特点

• 本报告对全球人类绒毛膜促性腺激素分泌(HCG) 市场进行了详细分析，包括市场规模和预测期 (2026-2033) 的复合年增长率，以 2025 年为基准年。
• 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本文根据以下参数，介绍了全球人类绒毛膜促性腺激素分泌(HCG) 市场主要企业的概况：公司概况、产品系列、主要亮点、财务绩效和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球人类绒毛膜促性腺激素分泌(HCG) 市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球人类绒毛膜促性腺激素分泌(HCG) 市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • PEST分析
  • 波特五力分析
  • 市场机会
  • 法规环境
  • 主要进展
  • 产业趋势

第四章 全球人类绒毛膜促性腺激素分泌(HCG) 市场：依产品类型划分 (2026–2033)

• 人类绒毛膜促性腺激素分泌
• 重组人类绒毛膜促性腺激素分泌

第五章 全球人类绒毛膜促性腺激素分泌(HCG) 市场：依治疗应用划分 (2026–2033)

• 男性性腺功能低下症
• 女性不孕症的治疗
• 少精症的治疗
• 隐睪症的治疗
• 慢性疼痛
• 其他的

第六章 全球人类绒毛膜促性腺激素分泌(HCG) 市场：依通路划分 (2026–2033)

• 医院药房
• 零售药房
• 网路药房

第七章 全球人类绒毛膜促性腺激素分泌(HCG) 市场：依地区划分 (2026–2033)

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第八章 竞争情势

• 热图分析
• 市占率分析（3x3矩阵）
• 公司简介
  • Merck &Co., Inc.
  • Ferring BV,Fresenius SE &Co.KGaA
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Lee BioSolutions
  • Serum Institute of India Pvt. Ltd
  • Scripps Laboratories
  • Sanzyme Biologics Pvt. Ltd.
  • VHB Medi Sciences Limited Bharat Serums And Vaccines Limited（BSV）
  • Zydus Lifesciences Ltd
  • Corona Remedies Pvt. Ltd.

第九章 分析师建议

• 机会
• 分析师意见
• Coherent Opportunity Map (COM)

第十章：参考文献与分析方法

• 参考
• 分析方法

Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at USD 2.96 Bn in 2026 and is expected to reach USD 3.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.68% from 2026 to 2033.

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study

• This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Market Segmentation

• By Product Type
  • Human Chorionic Gonadotropin
  • Recombinant Human Chorionic Gonadotropin
• By Therapeutic Application
  • Male Hypogonadism
  • Female Infertility Treatment
  • Oligospermic Treatment
  • Cryptorchidism Treatment
  • Chronic Pain
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Merck & Co., Inc.
  • Ferring B.V.
  • Fresenius SE & Co.KGaA,
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Lee BioSolutions
  • Serum Institute of India Pvt. Ltd.
  • Scripps Laboratories
  • Sanzyme Biologics Pvt. Ltd.
  • VHB Medi Sciences Limited Bharat Serums
  • Vaccines Limited (BSV)
  • Zydus Lifesciences Ltd
  • Corona Remedies Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Therapeutic Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Human Chorionic Gonadotropin
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Recombinant Human Chorionic Gonadotropin
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Male Hypogonadism
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Female Infertility Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oligospermic Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Cryptorchidism Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Chronic Pain
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Retail Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Online Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Ferring B.V.,Fresenius SE & Co.KGaA
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Lupin
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Lee BioSolutions
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Serum Institute of India Pvt. Ltd
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Scripps Laboratories
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Sanzyme Biologics Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV)
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Zydus Lifesciences Ltd
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Corona Remedies Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

9. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Section

• References
• Research Methodology
• About Us and Sales Contact